Targeting TPX2 to Enhance Metastasis Control and Radiosensitivity in Esophageal Squamous Cell Carcinoma Through PI3K/AKT Pathway Modulation
نویسندگان
doi
10.30498/ijb.2025.549444.4243چکیده
Background: Esophageal squamous cell carcinoma (ESCC) faces challenges of metastasis and variable radiosensitivity. The role of Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) in regulating these ESCC-related traits is unclear, needing investigation. Objective: This study investigates the functional role of TPX2 in regulating metastasis and radiosensitivity in ESCC. Methods: Differential expression of TPX2 in ESCC versus normal tissues was verified using bioinformatics (The Cancer Genome Atlas Program, Gene Expression Omnibus) and experimental analyses (Immunohistochemistry, Western blot). ESCC cell lines with stable TPX2 overexpression were established to evaluate effects on migration (wound healing assay), invasion (Transwell assay), and radiotherapy response via colony formation and apoptosis assays. In vivo, xenograft and lung homing mouse models (n=5/group) were employed to assess tumor growth, metastatic potential, and radiosensitivity. Additionally, exosome-mediated TPX2 transfer and its impacts on recipient cells were examined. Results: TPX2 was significantly upregulated in ESCC tissues and cell lines. TPX2 overexpression enhanced in vitro cell migration, invasion, and radiosensitivity, while promoting in vivo metastasis and modulating radiation response. Exosome-mediated TPX2 transfer induced comparable aggressive phenotypes in recipient cells. Mechanistically, TPX2 activated the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway (p-AKT/AKT ratio increased by ~2.5-fold), which directly contributed to enhanced metastatic potential and altered radiosensitivity. Conclusion: TPX2 acts as a key regulator of malignant progression and therapeutic response in ESCC by promoting epithelial-mesenchymal transition and activating the PI3K/AKT pathway.